|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Colvin H, Mizushima T, Eguchi H, Takigushi
S, Doki Y and Mori M: Gastroenterological surgery in Japan: The
past, the present and the future. Ann Gastroenterol Surg. 1:5–10.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seto Y, Kakeji Y, Miyata H and Iwanaka T:
National Clinical Database (NCD) in Japan for gastroenterological
surgery: Brief introduction. Ann Gastroenterol Surg. 2:80–81. 2017.
View Article : Google Scholar
|
|
4
|
Kaneko H, Otsuka Y, Kubota Y and
Wakabayashi G: Evolution and revolution of laparoscopic liver
resection in Japan. Ann Gastroenterol Surg. 1:33–43. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kobayashi S, Fukui K, Takeda Y, Nakahira
S, Tsujie M, Shimizu J, Miyamoto A, Eguchi H, Nagano H, Doki Y, et
al: Short-term outcomes of open liver resection and laparoscopic
liver resection: Secondary analysis of data from a multicenter
prospective study (CSGO-HBP-004). Ann Gastroenterol Surg. 2:87–94.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choi SH, Choi GH, Kim SU, Park JY, Joo DJ,
Ju MK, Kim MS, Choi JS, Han KH and Kim SI: Role of surgical
resection for multiple hepatocellular carcinomas. World J
Gastroenterol. 19:366–374. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ho MC, Huang GT, Tsang YM, Lee PH, Chen
DS, Sheu JC and Chen CH: Liver resection improves the survival of
patients with multiple hepatocellular carcinomas. Ann Surg Oncol.
16:848–855. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim JY, Sinn DH, Gwak GY, Choi GS, Saleh
AM, Joh JW, Cho SK, Shin SW, Carriere KC, Ahn JH, et al:
Transarterial chemoembolization versus resection for
intermediate-stage (BCLC B) hepatocellular carcinoma. Clin Mol
Hepatol. 22:250–258. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bolondi L, Burroughs A, Dufour JF, Galle
PR, Mazzaferro V, Piscaglia F, Raoul JL and Sangro B: Heterogeneity
of patients with intermediate (BCLC B) hepatocellular carcinoma:
Proposal for a subclassification to facilitate treatment decisions.
Semin Liver Dis. 32:348–359. 2012.PubMed/NCBI
|
|
11
|
Chang WT, Kao WY, Chau GY, Su CW, Lei HJ,
Wu JC, Hsia CY, Lui WY, King KL and Lee SD: Hepatic resection can
provide long-term survival of patients with non-early-stage
hepatocellular carcinoma: extending the indication for resection?
Surgery. 152:809–820. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Delis SG, Bakoyiannis A, Tassopoulos N,
Athanassiou K, Kelekis D, Madariaga J and Dervenis C: Hepatic
resection for hepatocellular carcinoma exceeding Milan criteria.
Surg Oncol. 19:200–207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu W, Wang K, Bao Q, Sun Y and Xing BC:
Hepatic resection provided long-term survival for patients with
intermediate and advanced-stage resectable hepatocellular
carcinoma. World J Surg Oncol. 14:622016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ng KK, Vauthey JN, Pawlik TM, Lauwers GY,
Regimbeau JM, Belghiti J, Ikai I, Yamaoka Y, Curley SA, Nagorney
DM, et al: Is hepatic resection for large or multinodular
hepatocellular carcinoma justified? Results from a
multi-institutional database. Ann Surg Oncol. 12:364–373. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Torzilli G, Belghiti J, Kokudo N, Takayama
T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E,
Donadon M, et al: A snapshot of the effective indications and
results of surgery for hepatocellular carcinoma in tertiary
referral centers: is it adherent to the EASL/AASLD
recommendations?: An observational study of the HCC East-West study
group. Ann Surg. 257:929–937. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ishizawa T, Hasegawa K, Aoki T, Takahashi
M, Inoue Y, Sano K, Imamura H, Sugawara Y, Kokudo N and Makuuchi M:
Neither multiple tumors nor portal hypertension are surgical
contraindications for hepatocellular carcinoma. Gastroenterology.
134:1908–1916. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim PT, Jang JH, Atenafu EG, Fischer S,
Greig PD, McGilvray ID, Wei AC, Gallinger S and Cleary SP: Outcomes
after hepatic resection and subsequent multimodal treatment of
recurrence for multifocal hepatocellular carcinoma. Br J Surg.
100:1516–1522. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nagano H, Kishimoto S, Kobayashi S,
Marubashi S, Eguchi H, Takeda Y, Tanemura M, Tomimaru Y, Noda T,
Umeshita K, et al: A safe protocol of intermittent hilar vascular
clamping for hepatic resection in cirrhosis.
Hepatogastroenterology. 56:1439–1444. 2009.PubMed/NCBI
|
|
19
|
Yamakado K, Miyayama S, Hirota S, Mizunuma
K, Nakamura K, Inaba Y, Yamamoto S, Matsuo K, Nishida N, Aramaki T,
et al: Prognosis of patients with intermediate-stage hepatocellular
carcinomas based on the Child-Pugh score: Subclassifying the
intermediate stage (Barcelona Clinic Liver Cancer stage B). Jpn J
Radiol. 32:644–649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rodríguez-Perálvarez M, Luong TV, Andreana
L, Meyer T, Dhillon AP and Burroughs AK: A systematic review of
microvascular invasion in hepatocellular carcinoma: diagnostic and
prognostic variability. Ann Surg Oncol. 20:325–339. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Truant S, Boleslawski E, Duhamel A, Bouras
AF, Louvet A, Febvay C, Leteurtre E, Huet G, Zerbib P, Dharancy S,
et al: Tumor size of hepatocellular carcinoma in noncirrhotic
liver: A controversial predictive factor for outcome after
resection. Eur J Surg Oncol. 38:1189–1196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tokumitsu Y, Tamesa T, Matsukuma S,
Hashimoto N, Maeda Y, Tokuhisa Y, Sakamoto K, Ueno T, Hazama S,
Ogihara H, et al: An accurate prognostic staging system for
hepatocellular carcinoma patients after curative hepatectomy. Int J
Oncol. 46:944–952. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Llovet JM, Schwartz M and Mazzaferro V:
Resection and liver transplantation for hepatocellular carcinoma.
Semin Liver Dis. 25:181–200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Majno P and Mazzaferro V: Living donor
liver transplantation for hepatocellular carcinoma exceeding
conventional criteria: Questions, answers and demands for a common
language. Liver Transpl. 12:896–898. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mazzaferro V, Llovet JM, Miceli R, Bhoori
S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi
GL, et al: Predicting survival after liver transplantation in
patients with hepatocellular carcinoma beyond the Milan criteria: A
retrospective, exploratory analysis. Lancet Oncol. 10:35–43. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wada H, Eguchi H, Noda T, Ogawa H, Yamada
D, Tomimaru Y, Tomokuni A, Asaoka T, Kawamoto K, Gotoh K, et al:
Selection criteria for hepatic resection in intermediate-stage
(BCLC stage B) multiple hepatocellular carcinoma. Surgery.
160:1227–1235. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang YF, Zhou J, Wei W, Zou RH, Chen MS,
Lau WY, Shi M and Guo RP: Intermediate-stage hepatocellular
carcinoma treated with hepatic resection: The NSP score as an aid
to decision-making. Br J Cancer. 115:1039–1047. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shimada M, Takenaka K, Fujiwara Y, Gion T,
Kajiyama K, Maeda T, Shirabe K and Sugimachi K: Des-gamma-carboxy
prothrombin and alpha-fetoprotein positive status as a new
prognostic indicator after hepatic resection for hepatocellular
carcinoma. Cancer. 78:2094–2100. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koike Y, Shiratori Y, Sato S, Obi S,
Teratani T, Imamura M, Yoshida H, Shiina S and Omata M:
Des-gamma-carboxy prothrombin as a useful predisposing factor for
the development of portal venous invasion in patients with
hepatocellular carcinoma: A prospective analysis of 227 patients.
Cancer. 91:561–569. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Amano H, Tashiro H, Oshita A, Kobayashi T,
Tanimoto Y, Kuroda S, Tazawa H, Itamoto T, Asahara T and Ohdan H:
Significance of platelet count in the outcomes of hepatectomized
patients with hepatocellular carcinoma exceeding the Milan
criteria. J Gastrointest Surg. 15:1173–1181. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng J, Zhao P, Liu J, Liu X and Wu X:
Preoperative aspartate aminotransferase-to-platelet ratio index
(APRI) is a predictor on postoperative outcomes of hepatocellular
carcinoma. Medicine (Baltimore). 95:e54862016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ho MC, Hasegawa K, Chen XP, Nagano H, Lee
YJ, Chau GY, Zhou J, Wang CC, Choi YR, Poon RT and Kokudo N:
Surgery for intermediate and advanced hepatocellular carcinoma: A
consensus report from the 5th asia-pacific primary liver cancer
expert meeting (APPLE 2014). Liver Cancer. 5:245–256. 2016.
View Article : Google Scholar : PubMed/NCBI
|
